Biography
Khadija Blan is a second-year Industrial Pharmacy student at Maaref University of Applied Sciences. Her academic interests focus on pharmaceutical research, drug development, and artificial intelligence. She is particularly interested in exploring how artificial intelligence can help identify new therapeutic uses for existing medicines through drug repurposing. She aims to understand how this innovative approach can contribute to discovering new treatment opportunities, reducing drug development costs, and improving patient care.
Conference contributions 1
AI-POWERED DRUG REPURPOSING
Finding New Uses for Existing Medicines
Drug repurposing, also known as drug repositioning, involves identifying new therapeutic uses for existing medicines. This approach has gained attention because traditional drug development is often time-consuming and expensive. Artificial intelligence (AI) can support drug repurposing by analyzing biological and medical data to identify potential relationships between existing drugs and diseases. This review explores how AI can accelerate drug discovery by predicting new therapeutic applications and identifying promising drug candidates. Its potential applications include cancer, neurodegenerative disorders, and rare diseases. By utilizing existing medicines, this approach may reduce research time and development costs. However, AI predictions alone cannot guarantee drug safety or effectiveness. Laboratory experiments, clinical trials, and regulatory assessments remain essential to validate potential treatments. Challenges such as limited datasets, poor data quality, and difficulties interpreting AI predictions may also affect reliability. In conclusion, combining AI with experimental research could improve drug discovery efficiency and support the development of innovative therapeutic options.